NCT05357248 - Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 10, 2022

Primary Completion Date

November 11, 2022

Study Completion Date

December 7, 2022

Conditions

Non-alcoholic SteatohepatitisNon-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty Liver

Interventions

DEVICE

BT-NCBT-00X

the intervention group will consist of 20 patients to receive the BT-NCBT-00X treatment for 90 days. They will receive a baseline MRI-PDFF, Fibroscan and have the tests repeated at 90 days.

Trial Locations (2)

85224

Arizona Liver Health, Chandler

85381

Arizona Liver Health, Peoria